Patent details

EP3021838 Title: TREATMENT FOR OBESITY

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3021838
WO Application Number:
US2014047186
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP14825724.9
WO Publication Number:
WO2015010014
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Ireland (IE)
Publications:

Dates

Filing date:
18/07/2014
Grant date:
27/05/2020
EP Publication Date:
25/05/2016
WO Publication Date:
22/01/2015
Claims Translations Received Date:
Claims Translation B1 Received Date:
25/08/2020
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
27/05/2020
EP B1 Publication Date:
27/05/2020
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
17/07/2034
Lapsed By Expiration Date:
Patent Validated Date:
02/09/2020
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
09/08/2023
 
 

 

Name:
Axsome Malta Ltd.
Address:
Pinto Business Centre, Level 4, Office 4 Mill Street, QRM 3104, Qormi, Malta (MT)

From:
09/08/2023
 
 

 

Name:
SK Biopharmaceuticals Co., LTD
Address:
99 Seorin-dong Jongro-gu Seoul 110-110, SOUTH KOREA, Korea (Republic) (KR)

Historical Applicant/holder

From:
27/05/2020
To:
09/08/2023

 

Name:
Jazz Pharmaceuticals Ireland Limited
Address:
Waterloo Exchange Waterloo Road, Dublin 4, Ireland (IE)

From:
27/05/2020
To:
09/08/2023

 

Name:
SK Biopharmaceuticals Co., LTD
Address:
99 Seorin-dong Jongro-gu Seoul 110-110, SOUTH KOREA, Korea (Republic) (KR)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
28/08/2020
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
KHAYRALLAH, Moise A.
Address:
Chapel Hill, North Carolina 27516-2588, United States of America (US)

2

Name:
BREAM, Gary
Address:
Cary, North Carolina 27519, United States of America (US)

3

Name:
BUTTS, Stephen E.
Address:
Holly Springs, North Carolina 27540, United States of America (US)

Priority

Priority Patent Number:
201361847593 P
Priority Date:
18/07/2013
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
A61K 31/27; A61P 3/04;

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
33/23
Publication date:
16/08/2023
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
EP3
Journal edition number:
36/20
Publication date:
02/09/2020
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
22/20
Publication date:
27/05/2020
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202022
Publication date:
27/05/2020
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202301633B
Date Registered:
09/08/2023
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
dr. R.C. van Duijvenbode c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
SK Biopharmaceuticals Co., LTD
Address:
99 Seorin-dong Jongro-gu Seoul 110-110, SOUTH KOREA, Korea (Republic) (KR)

2

Name:
Axsome Malta Ltd.
Address:
Pinto Business Centre, Level 4, Office 4 Mill Street, QRM 3104, Qormi, Malta (MT)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/07/2025
Annual Fee Number:
12
Annual Fee Amount:
600 Euro
Last Annual Payment Date:
25/07/2024
Last Annual Fee Paid Number:
11
Last Annual Fee Paid Amount:
500 Euro
Payer:
IPAN GmbH
Filing date Document type Document Description Number of pages File Type
01/09/2020 Outgoing Correspondence Letter no formal defects 1 PDF /6/9/9/8/5/0800558996/docs/ep14825724.9_1_363906l271.pdf
25/08/2020 Claims First filed claims 5 PDF /6/9/9/8/5/0800558996/docs/ep14825724.9_0_claims20200825084628458.pdf